NCT02622529

Brief Summary

This study aims to investigate patients' experience of awake surgery of the brain. Patients therefore must suffer a disease that makes the technique of awake craniotomy necessary. In more detail, the investigators are performing this study in order to investigate the influence of fear on pain perception during surgery for patients undergoing awake surgery for lesions within the brain. In the event of finding a correlation between fear of the surgery and intraoperative pain perception, the investigators aim to reduce possible fear beforehand. An additional goal of the investigators is to identify psychological consequences of awake craniotomy timely and admit patients to an adequate therapy if necessary. There will be no changes regarding the actual treatment of the disease. In case of a consent, the patient will receive questionnaires at three timepoints: 1. day before surgery. 2. third day after surgery. 3. at 3-6 months postoperatively at the outpatient clinics. The benefit of participating in this study is the possibility of detecting psychological consequences of awake craniotomy at an early stage. If required, patients will then receive treatment timely. There are no additional risks. Theoretically there is only a data risk after analysis. Patients are free to decide if they want to participate within this study. There are no changes in the actual treatment if patients deny participation. In case of participation, patients have the right to quit at any time with no reasoning at all. During the study investigators are collecting health-related data. If patients quit before the study end, data will still be used in pseudonymized form. After 10 years, data will be destroyed. In case of participation the only duty for the patient is to fill out the questionnaires at the above mentioned three time points. The investigators conduct this study based on all rules of law regarding data protection. Investigators only use the collected data in relation to this study. All investigators are under obligation to secrecy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

November 30, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 4, 2015

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

July 18, 2018

Status Verified

July 1, 2018

Enrollment Period

2.3 years

First QC Date

November 30, 2015

Last Update Submit

July 17, 2018

Conditions

Keywords

Awake craniotomyPsychological consequencesFear and Anxiety

Outcome Measures

Primary Outcomes (1)

  • Changes in Pain and Anxiety (NRS)

    Numeric rating scale (NRS). (Kremer et al., 1981; Farrar et al., 2000) Preoperative assessment of anxiety is evaluated using the NRS on a scale of 0-10. Intraoperatively the NRS is used at three time points to assess for anxiety and pain. 0 indicates the absence of pain or anxiety, whereas 10 indicates the maximum possible patients' perception of pain or anxiety

    1st day preop, intraoperatively, 3rd day postop, 6th month postop

Secondary Outcomes (6)

  • Cognition

    1st preoperative day

  • Changes in General psychological symptoms

    1st preoperative day, 3rd day postoperative visit, 6th month postop

  • Changes in General psychological symptoms

    1st preoperative day, 6th month postop

  • Changes in Stress and Anxiety

    1st preoperative day, 3rd day postoperative visit, 6th month postop

  • Changes in Stress and Anxiety

    1st preoperative day, 3rd day postoperative visit, 6th month postop

  • +1 more secondary outcomes

Study Arms (1)

Screening through Questionnaires

All of the patients within this single existent Arm will receive the questionnaires.

Other: Screening through questionnaires

Interventions

Distribution of Questionnaires to every participant within the single existent Arm at three times.

Screening through Questionnaires

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive ongoing recruitment through investigator(s) in daily clinical practice (consultations). The subjects will receive the consent form with an address and phone number indicated where further questions regarding the study can be discussed directly with the project leader. This will take place at least one week before the hospitalisation.

You may qualify if:

  • Written informed consent
  • Low grade glioma, cavernoma, metastasis
  • age ≥ 18 years \< 65 years

You may not qualify if:

  • No given operability for anaesthetic reasons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cantonal Hospital St. Gallen

Sankt Gallen, St.Gallen, 9007, Switzerland

Location

Related Publications (14)

  • Verordnung über die Humanforschung mit Ausnahme der klinischen Versuche (Humanforschungsverordnung, HFV) / Ordonnance relative à la recherche sur l'être humain à l'exception des essais cliniques (Ordonnance relative à la recherche sur l'être humain, ORH) / Ordinance on Human Research with the Exception of Clinical Trials (Human Research Ordinance, HRO)

    BACKGROUND
  • von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007 Oct 16;4(10):e296. doi: 10.1371/journal.pmed.0040296.

    PMID: 17941714BACKGROUND
  • Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007 Oct 16;4(10):e297. doi: 10.1371/journal.pmed.0040297.

    PMID: 17941715BACKGROUND
  • BECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561-71. doi: 10.1001/archpsyc.1961.01710120031004. No abstract available.

    PMID: 13688369BACKGROUND
  • Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002 Feb;52(2):69-77. doi: 10.1016/s0022-3999(01)00296-3.

    PMID: 11832252BACKGROUND
  • Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994 Mar;23(2):129-38.

    PMID: 8080219BACKGROUND
  • Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain. 2000 Dec 1;88(3):287-294. doi: 10.1016/S0304-3959(00)00339-0.

    PMID: 11068116BACKGROUND
  • Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry. 1983 Jul;40(7):812. doi: 10.1001/archpsyc.1983.01790060110016. No abstract available.

    PMID: 6860082BACKGROUND
  • Griesel D, Wessa M, Flor H. Psychometric qualities of the German version of the Posttraumatic Diagnostic Scale (PTDS). Psychol Assess. 2006 Sep;18(3):262-8. doi: 10.1037/1040-3590.18.3.262.

    PMID: 16953729BACKGROUND
  • Gräfe K, Zipfel S, Herzog W, Löwe B. Screening psychischer Störungen mit dem "Gesundheitsfragebogen für Patienten (PHQ-D)" Daignostica 2004; 50(4): 11

    BACKGROUND
  • Keefe FJ, Lumley M, Anderson T, Lynch T, Studts JL, Carson KL. Pain and emotion: new research directions. J Clin Psychol. 2001 Apr;57(4):587-607. doi: 10.1002/jclp.1030.

    PMID: 11255208BACKGROUND
  • Kremer E, Atkinson HJ, Ignelzi RJ. Measurement of pain: patient preference does not confound pain measurement. Pain. 1981 Apr;10(2):241-248. doi: 10.1016/0304-3959(81)90199-8.

    PMID: 7267140BACKGROUND
  • Milian M, Tatagiba M, Feigl GC. Patient response to awake craniotomy - a summary overview. Acta Neurochir (Wien). 2014 Jun;156(6):1063-70. doi: 10.1007/s00701-014-2038-4. Epub 2014 Mar 5.

    PMID: 24595540BACKGROUND
  • Radbruch L, Loick G, Kiencke P, Lindena G, Sabatowski R, Grond S, Lehmann KA, Cleeland CS. Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage. 1999 Sep;18(3):180-7. doi: 10.1016/s0885-3924(99)00064-0.

    PMID: 10517039BACKGROUND

Related Links

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Werner Surbeck, MD

    Department of Neurosurgery, Cantonal Hospital St. Gallen, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
med. pract.

Study Record Dates

First Submitted

November 30, 2015

First Posted

December 4, 2015

Study Start

November 1, 2015

Primary Completion

March 1, 2018

Study Completion

July 1, 2018

Last Updated

July 18, 2018

Record last verified: 2018-07

Locations